INIS
mutations
80%
plasma
80%
patients
50%
blood cells
50%
bone marrow
30%
myeloid leukemia
30%
bone marrow cells
30%
kinases
20%
messenger-rna
20%
therapy
10%
diseases
10%
sensitivity
10%
rna
10%
genes
10%
blood
10%
blasts
10%
Medicine and Dentistry
Blood Cell
100%
Plasma
80%
Patient
50%
Chronic Myelogenous Leukemia
30%
Bone Marrow
30%
Bone Marrow Cell
30%
Messenger RNA
20%
Diseases
10%
Combination Therapy
10%
Oncogene
10%
RNA
10%
Imatinib
10%
Phosphotransferase
10%
Abelson Kinase
10%
Analysis
10%
Cells
10%
Blood
10%
Biochemistry, Genetics and Molecular Biology
Mutation
80%
Bone
60%
Peripheral Blood Cell
50%
Myeloid
30%
Kinase
20%
Messenger RNA
20%
Imatinib
10%
RNA
10%
Physics
Mutation
80%
Bone Marrow
60%
RNA
10%
Heterogeneity
10%
Alternatives
10%
Therapy
10%
Domains
10%
Blood
10%